The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.
LATEST NEWS
Keeping an "Eye on Innovation" Through News & Analysis
Glaucoma 360: Promising data as the industry considers value
“Innovation remains the largest driver of healthcare cost increase,” said David Parke II, MD, American Academy of Ophthalmology CEO, during the Glaucoma Research Foundation’s (GRF) ...
Ranibizumab More Cost-Effective Than PRP
The use of ranibizumab 0.5 mg for proliferative diabetic retinopathy (PDR) compared with panretinal photocoagulation (PRP) appeared to be more cost effective for patients with ...
AbbVie and Allergan Are Going to Be Just Fine
Media coverage of AbbVie’s (NYSE: ABBV) acquisition of Allergan (NYSE: AGN) in June was both bullish and bearish. In our initial coverage, we took a ...
Soft CL slows myopia in children
Globally, the myopia market may be worth upwards of $28 billion by 2026, with single prescription corrective lenses holding a significant market share, according to ...
Lucentis and Eylea patent expirations in the micro-crystal ball
Over the past 10 years, the Dow Jones Industrial Average has seen a 10-year climb with small calendar-year dips seen in 2015 (-2.23%) and 2018 ...
OIS Index Posts a Strong Finish to 2019
The OIS Index of ophthalmic stocks made a strong comeback in Q4-2019, following a rough Q3. The index gained 16.2% in Q4, slightly underperforming the ...
LATEST PODCASTS
Candid Conversations With Ophthalmology's Innovators & Business Leaders
TESTIMONIALS
Why People Attend OIS
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.